Taken together, these observations suggest that fibrotic disease progression in SSc may be driven by distinct mechanisms in lung and skin, where IL6 and fibrosis-associated macrophages are more closely associated with lung function while other targets such as TGFβ and myofibroblasts may be more closely associated with skin fibrosis. Here, IL6 is linked to systemic sclerosis.